Stay updated on Lanadelumab in Preventing Angioedema Attacks Clinical Trial

Sign up to get notified when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:46:37.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and deleted Revision: v3.5.0 from the version history.
    Difference
    0.2%
    Check dated 2026-04-17T02:17:13.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Visual/UI adjustments to the Record History page without any changes to study data or statuses.
    Difference
    0.1%
    Check dated 2026-04-09T20:54:28.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T04:40:00.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    - Revision label updated from v3.4.2 to v3.4.3 in the page footer. - No impact on study data or user workflow.
    Difference
    0.1%
    Check dated 2026-03-11T20:07:19.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    A new revision label, v3.4.2, was added to the history. The deleted notices include a government funding status notice and the older v3.4.1 entry, reflecting administrative updates to the page's version history.
    Difference
    0.7%
    Check dated 2026-02-11T05:14:44.000Z thumbnail image

Stay in the know with updates to Lanadelumab in Preventing Angioedema Attacks Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.